F15.921

Clinical Causes: Use of stimulants like amphetamines, methamphetamines, or other similar substances. High doses or rapid intake of stimulant drugs. Combination of stimulant use with other substances such as alcohol or sedatives. Pre-existing mental health conditions that may predispose to adverse reactions. Metabolic or neurological factors that affect drug metabolism.

Key Symptoms: Altered mental status, including confusion and disorientation. Hallucinations, both visual and auditory. Agitation and restlessness. Rapid speech and erratic behavior. Delusions or paranoid thoughts. Elevated heart rate and blood pressure. Dilated pupils. Sweating and chills. Impaired motor coordination. In severe cases, loss of consciousness or coma.

Diagnosis Path: Diagnosis involves a comprehensive clinical assessment, including a detailed history of substance use and physical examination. Healthcare providers may perform blood or urine tests to detect the presence of stimulants in the system. Observing the patient's mental state and noting signs of delirium are crucial. Differential diagnosis considers other causes of delirium such as infections, metabolic disturbances, or medication effects. Medical professionals also evaluate the severity and setting of substance use to guide further management.

Treatment Protocols: Managing stimulant-induced intoxication delirium includes supportive care and monitoring. Immediate interventions may involve ensuring airway stability, hydration, and controlling agitation with suitable medications. In some cases, sedatives or antipsychotic drugs are used cautiously. Treating underlying complications, such as cardiovascular instability or seizures, is essential. Long-term treatment may involve substance use counseling, behavioral therapies, and addressing underlying mental health issues to prevent recurrence. Hospitalization may be necessary for severe cases to provide a safe environment and specialized care.